OR WAIT null SECS
Making the Grade: The Importance of Using the Correct Excipient Grade in Drug Products
With an ever-growing market driving technological advances, there is always work to be done in drug manufacturing.
Advanced oral dosage forms allow for modulation of controlled- and sustained-release profiles.
Packaging and packaging line innovations are addressing the industry’s growing use of biologics.
What are the lessons gleaned from a product’s E&L lifetime?
There are considerations companies may want to consider before seeking out a service provider.
The Biosimilars Landscape
May 07, 2024
ProPharm and PBL have introduced a fully automated, enclosed cell factory manufacturing device.
The two companies will combine their cell therapy platforms to develop convertibleCAR programs targeting solid tumors.
May 06, 2024
The request for more information was received weeks after an application to the FTC was refiled to approve the deal.
The use of appropriate taste-masking and appearance technologies can facilitate patient compliance.
May 05, 2024
A comparison between polysorbates and HPβCD determines the better stabilizer for biologics formulation.
May 04, 2024
A new draft guidance issued by FDA covers human- and animal-derived materials used in the manufacture of advanced therapy medicinal products.
May 03, 2024
Cormica’s first US Acquisition is intended to support to organic growth of TPM laboratories.
The loan is intended to support Ennogen’s growth as it looks to international acquisitions.
In this exclusive Drug Digest video interview, Chris Spivey, Director, Industry Relations and Strategic Partnerships, talks with industry experts about various aspects of drug product stability testing.
Technological advances are helping advance biologics development and manufacturing and reduce bottlenecks.